also showed that clusters of TILs in BRAFV600E/K melanoma were more likely to be associated with a better prognosis and response to immunotherapy than in NRAS-mutated or BRAF/NRAS wild-type melanoma.31 The gene discussed is BRAF; the disease is melanoma.